Health care resource utilization and costs in patients receiving long-acting injectable vs oral antipsychotics: A comparative analysis from the Disease Recovery Evaluation and Modification (DREaM) study

MLA

Anirban Basu, et al. “Health Care Resource Utilization and Costs in Patients Receiving Long-Acting Injectable vs Oral Antipsychotics: A Comparative Analysis from the Disease Recovery Evaluation and Modification (DREaM) Study.” Journal of Managed Carespecialty Pharmacy, vol. 28, no. 10, Sept. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4e93be2da68ababa6ae9e6327e9beb56&authtype=sso&custid=ns315887.

APA

Anirban Basu, Carmela Benson, Ibrahim Turkoz, Charmi Patel, Pamela Baker, & Brianne Brown. (2022). Health care resource utilization and costs in patients receiving long-acting injectable vs oral antipsychotics: A comparative analysis from the Disease Recovery Evaluation and Modification (DREaM) study. Journal of Managed Carespecialty Pharmacy, 28(10).

Chicago

Anirban Basu, Carmela Benson, Ibrahim Turkoz, Charmi Patel, Pamela Baker, and Brianne Brown. 2022. “Health Care Resource Utilization and Costs in Patients Receiving Long-Acting Injectable vs Oral Antipsychotics: A Comparative Analysis from the Disease Recovery Evaluation and Modification (DREaM) Study.” Journal of Managed Carespecialty Pharmacy 28 (10). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4e93be2da68ababa6ae9e6327e9beb56&authtype=sso&custid=ns315887.